Corticosteroids Market to Reach $10.29 Billion by 2035

Corticosteroids market was valued at $6.20 billion in 2025 and is projected to reach $10.29 billion by 2035, growing at a CAGR of 5.2% during the forecast period (2026–2035). The rising prevalence of chronic inflammatory and respiratory diseases is significantly strengthening demand for corticosteroid-based therapies across global healthcare systems. According to the World Health Organisation, chronic respiratory diseases such as asthma and COPD affect over 550 million people worldwide, driving sustained demand for anti-inflammatory medications, including corticosteroids. These drugs play a critical role in reducing inflammation, suppressing immune responses, and managing disease progression across multiple therapeutic areas. The increasing burden of allergic and autoimmune disorders is further accelerating market expansion.

Browse the full report description of “Corticosteroids Market Size, Share & Trends Analysis Report, By Product Type (Glucocorticoids, Mineralocorticoids), By Application (Respiratory Diseases, Dermatological Disorders, Autoimmune & Inflammatory Diseases, Allergic Conditions, Endocrine Disorders), By Drug Class Potency (Low Potency, Medium Potency, High Potency), By Formulation Type (Solid Formulations, Liquid Formulations, Semi-Solid, Aerosol/Inhalers), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/corticosteroids-market-size

Data from the International Federation of Pharmaceutical Manufacturers & Associations highlights that immunology and inflammation-related therapies are among the fastest-growing pharmaceutical segments globally. Additionally, the U.S. Food and Drug Administration continues to approve advanced corticosteroid formulations, including inhalers and topical therapies, supporting innovation and product diversification. Expanding healthcare access and rising pharmaceutical spending, particularly in emerging economies, are also contributing to increased corticosteroid adoption across hospitals and outpatient care settings.

Rising Respiratory Disease Burden Driving Corticosteroid Demand

Globally, the increasing incidence of respiratory diseases is a key macro driver for the corticosteroids market. According to WHO data, asthma alone affects more than 260 million people globally, with millions requiring long-term corticosteroid therapy for disease management. Air pollution, urbanisation, and lifestyle changes are significantly contributing to rising respiratory disease prevalence, particularly in the Asia-Pacific regions. This growing patient pool is reinforcing demand for inhaled corticosteroids and combination therapies, especially in aerosol/inhaler formulations, which enable targeted drug delivery and improved treatment outcomes.

Key Leaders Transforming the Corticosteroids Market

The key players in the corticosteroids market include Pfizer Inc., GSK plc, AstraZeneca plc, Sanofi, and Cipla Ltd. These companies are actively focusing on product innovation, partnerships, and geographical expansion to strengthen their market presence:

• In February 2026, received full results from the positive Phase III KALOS and LOGOS trials, which were published in The Lancet Respiratory Medicine, demonstrating that BREZTRI Aerosphere (an inhaled triple therapy composed of the corticosteroid budesonide, glycopyrronium, and formoterol fumarate) provided statistically significant and clinically meaningful improvements in lung function and reduced exacerbations for patients with uncontrolled asthma.
• In February 2026, Sanofi and Regeneron’s Dupixent was approved in the US as the first and only medicine for allergic fungal rhinosinusitis

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Application
  • By Drug Class Potency
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

• Competitive Landscape – Pfizer Inc., GSK plc, AstraZeneca plc, Sanofi, Cipla Ltd., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Corticosteroids Market Report Segment

By Product Type

• Glucocorticoids
• Mineralocorticoids

By Application

• Respiratory Diseases
• Dermatological Disorders
• Autoimmune & Inflammatory Diseases
• Allergic Conditions
• Endocrine Disorders

By Drug Class Potency

• Low Potency Corticosteroids
• Medium Potency Corticosteroids
• High Potency Corticosteroids

By Formulation Type

• Solid Formulations
• Liquid Formulations
• Semi-Solid
• Aerosol / Inhalers

Global Corticosteroids Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/corticosteroids-market-size